At a glance
DSTL charges 0.39% a year, above the 0.31% average of the 3 funds most like it (the 3rd cheapest of 4). It has $2.12B in assets, the 2nd largest of that group; it paid 1.07% of its price in distributions over the past 12 months, quarterly. Over the past year it returned +18.2% with distributions reinvested (S&P 500: +11.5%), 2nd of those 4 funds; over three years it returned +18.7% a year. At its worst it fell 32.8% in the 2020 crash (S&P 500: 33.7%) and 20.1% in the 2022 bear market (S&P 500: 24.5%), and was back at its earlier high 3 months and 9 months after the lows. Its ten largest positions make up 20.1% of the fund, out of 107 in all.
The short version
Distillate US Fundamental Stability & Value ETF (DSTL) is an actively managed fund. It held 107 large US-listed companies as of June 30, 2026, picked for steady cash flow, low debt and cheap prices relative to free cash flow. It may appeal to investors who want large-company stocks with a value and quality tilt. Its 0.39% expense ratio is above the 0.31% average of similar funds.
Price history
The interactive chart needs JavaScript.
DSTL +18.2% over the year to Oct 27, 2026, total return with distributions reinvested.
How it has behaved
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | Since start | |
|---|---|---|---|---|---|---|
| DSTL official prospectus, to Dec 31, 2025 | — | +8.62% | — | +11.63% | — | +14.05% |
| DSTL price data to Oct 27, 2026 | +17.1% | +18.2% | +18.7% | +11.3% | — | +15.1% |
- Over the year to Oct 27, 2026, DSTL returned +18.2%, 2nd of 4 among similar funds.
- Its 5-year annualized return was +11.3%.
- In the 2020 COVID crash it fell 32.8% and regained its old high 2.5 months after the low.
- Its worst full calendar year was 2022 (-10.7%); its best was 2019 (+35.5%).
- The deepest fall in its price history was 33.1% (Feb 12, 2020 to Mar 23, 2020), recovered by Jul 22, 2020.
Show as a table
| Year | Price data | Prospectus (official) |
|---|---|---|
| 2026 (to date) | +17.1% | — |
| 2025 | +8.7% | +8.62% |
| 2024 | +12.8% | +12.83% |
| 2023 | +22.7% | +22.67% |
| 2022 | -10.7% | -10.58% |
| 2021 | +28.9% | +28.91% |
| 2020 | +19.3% | +19.22% |
| 2019 | +35.5% | +34.91% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Before this security existed |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Lost 32.8% over that stretch · deepest drop along the way 32.8%, back to its old high 2.5 months after the low |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Lost 18.9% over that stretch · deepest drop along the way 20.1%, back to its old high 9.4 months after the low |
Dividends and income
Show as a table
| Year | Per share | Change |
|---|---|---|
| 2026 (to date) | $0.5400 | |
| 2025 | $0.7700 | +5.5% |
| 2024 | $0.7300 | +14.1% |
| 2023 | $0.6400 | +18.5% |
| 2022 | $0.5400 | +14.9% |
| 2021 | $0.4700 | +56.7% |
| 2020 | $0.3000 | 0.0% |
| 2019 | $0.3000 |
What's inside
As of Jun 30, 2026, the fund held 107 securities; the ten largest made up 20.05% of assets.
| Holding | Weight | |
|---|---|---|
| AbbVie Inc | 3.35% | |
| Merck & Co Inc | 2.94% | |
| QUALCOMM Inc | 2.37% | |
| Booking Holdings Inc | 1.81% | |
| Uber Technologies Inc | 1.75% | |
| Salesforce Inc | 1.71% | |
| Altria Group Inc | 1.59% | |
| Cigna Group | 1.51% | |
| T-Mobile US Inc | 1.51% | |
| Comcast Corp | 1.50% | |
| Marathon Petroleum Corp | 1.49% | |
| UnitedHealth Group Inc | 1.40% | |
| Adobe Inc | 1.32% | |
| Abbott Laboratories | 1.31% | |
| Automatic Data Processing Inc | 1.28% |
By country
United States 93.73%Ireland 3.98%United Kingdom 1.97%By asset type
Stocks 99.68%By sector
Sectors of the companies held, for the 59.8% of the fund in companies that have a stock page here; other holdings and cash aren't classified. Source: N-PORT holdings report as of Jun 30, 2026. Cash, money-market funds and derivatives are shown separately from the securities list.What changed recently
- Over the three months to Jun 30, 2026, investors added a net $266.6M (creations minus redemptions, per the N-PORT report).
- Monthly total returns reported for that quarter: +3.02%, +0.84%, -0.15%.
How it works
DSTL does not track an index. Its adviser, Distillate Capital Partners, picks the stocks using its own rules. It starts with US-listed companies that pass tests for profitability, past cash flow and trading liquidity. It then ranks them on two measures. The first is valuation, based on free cash flow yield. That compares a company's normalized free cash flow (free cash flow adjusted to remove one-off items) with its enterprise value (its market value plus its debt). The second is cash flow stability, meaning how much past and projected cash flows swing.
From the most undervalued companies, the fund buys only large caps, defined as roughly the 500 largest US-listed companies by free-float market value. It usually avoids heavily indebted firms, using the adviser's own debt-to-income test. A stock is sold when it becomes overvalued, takes on too much debt, reports a drop in income that fails the debt test, or no longer passes the cash flow stability test. The adviser can also include or exclude companies at its discretion.
The portfolio is reviewed at least once a quarter. Portfolio turnover was 70%, so holdings change often. The fund uses no derivatives or leverage, and at least 80% of net assets goes into US assets.
What it really costs
- DSTL charges 0.39% a year, versus an average of 0.31% for the similar funds below (3rd of 4, cheapest first).
- Using the prospectus's standard example, $10,000 invested would cost about $40 in the first year and $493 over 10 years (assuming a 5% annual return).
| Cost of $10,000 (SEC example) | 1 yr | 3 yrs | 5 yrs | 10 yrs |
|---|---|---|---|---|
| DSTL | $40 | $125 | $219 | $493 |
In a retirement portfolio
It holds a broad basket of 107 large US companies with a value and quality tilt, so it could fill the US stock part of a portfolio rather than serve as a niche bet.
DSTL could make up the large-company US stock part of a long-term portfolio, with a tilt toward cheaper, less indebted companies. It is still a stock fund. In the 2020 COVID crash it fell 33.1% from peak to trough and recovered in about four months. In the 2022 bear market it dropped 20.1% and did not regain its peak until July 2023, about nine months after the low. Its worst calendar year was 2022, at -10.58%. Anyone forced to sell shares during drops like these would lock in losses. The fund launched in 2018, so it has no record from 2008.
The yield was 1.07% as of October 27, 2026, paid quarterly, so DSTL is not built for income. Its 0.39% expense ratio is above the 0.31% average of its closest peers. Past results don't predict the future, and a plan should look at the whole portfolio, not one fund.
Who it may suit — and who should look elsewhere
May suit
- Investors who want large US companies screened for stable free cash flow, cheap valuations and low debt, rather than weighted by market size.
- Long-term holders comfortable with a fund that fell 20.1% in 2022 and took until July 2023 to recover.
- People who want more health care stocks, such as AbbVie and Merck, its two largest holdings as of June 30, 2026.
Look elsewhere if
- Cost-focused investors: the 0.39% expense ratio ranks 3rd of 4 among similar funds, above Principal Value ETF's 0.15%.
- Those who need meaningful income, since the yield was just 1.07% as of October 27, 2026.
- Investors who prefer a rules-based index fund, since DSTL is actively managed, relies on the adviser's own measures and had 70% turnover.
Close alternatives
Matched by holdings overlap from the latest N-PORT reports.
Net assets from each fund's latest N-PORT or annual report where available. Returns through Oct 27, 2026.Questions investors ask
What does DSTL invest in?
DSTL invests in large US-listed companies that its adviser, Distillate Capital Partners, judges to be undervalued, with stable cash flows and limited debt. As of June 30, 2026, it held 107 stocks, and the top 10 made up about 20% of assets. The largest holdings were AbbVie at about 3.4%, Merck at 2.9%, Qualcomm at 2.4%, Booking Holdings at 1.8% and Uber at 1.7%. As of January 2026, the prospectus listed health care, industrials and information technology as its largest sector exposures.
Is DSTL good for retirement?
DSTL could serve as the US stock part of a retirement portfolio, but it carries full stock market risk. It fell 33.1% in the 2020 COVID crash and 20.1% during the 2022 bear market. After 2022 it took until July 2023 to regain its peak. The yield was 1.07% as of October 27, 2026, so it provides little income. Retirees who might need to sell shares in a downturn may want to weigh that history against the rest of their portfolio.
What's the difference between DSTL and COWZ?
Both funds favor companies with strong free cash flow, and their holdings overlapped by about 37% in the latest N-PORT reports. DSTL costs 0.39% a year, while Pacer US Cash Cows 100 ETF (COWZ) costs 0.49%. COWZ is much larger, with about $18.7 billion in net assets versus about $2.1 billion for DSTL. Over the past year, COWZ returned 26% as of October 29, 2026, compared with 18.2% for DSTL as of October 27. Over three years, DSTL led, at 18.7% a year versus 16.9%.
Does DSTL pay dividends?
Yes. DSTL pays dividends quarterly. Over the 12 months to October 27, 2026, it paid about $0.73 per share, which works out to a yield of 1.07%. That is a modest payout. The fund picks stocks for free cash flow, valuation and balance sheet strength, not for high dividends. Investors looking mainly for income may want to compare it with funds built around dividend yield.
How has DSTL performed since it launched?
DSTL returned 14.05% a year on average from its October 2018 launch through December 31, 2025, according to its prospectus. Its five-year average was 11.63% a year, and its 2025 return was 8.62%. Its best calendar year was 2019, at 34.91%, and its worst was 2022, at -10.58%. Its best and worst quarters both came in 2020: down 19.39% in the first quarter and up 22.57% in the second. Past returns don't predict future results.